This site is currently being updated.Thank you for your patience. We will be back soon.
THERAtRAME discovers and develops first-in-class small molecules targeting the tRNA epitranscriptomics for the benefit of cancer patients.
Avenue de l'Hopital 1
4000 Liège
Belgium
info@theratrame.com